Evaluation of the impact of the proteasome inhibitor on calcium channel expression in cardiomyocytes treated with doxorubicin

1. Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev. 2004;56:185-229.10.1124/pr.56.2.6Search in Google Scholar

2. Praet M, Pollakis G, Goormaghtigh E, Ruysschaert JM. Damages of the mitochondrial membrane in Adriamycin treated mice. Cancer Lett. 1984;25:89-96.10.1016/S0304-3835(84)80030-0Open DOISearch in Google Scholar

3. Zhou S, Starkov A, Froberg MK, Leino RL, Wallace KB. Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin. Cancer Res. 2001;61:771-7.Search in Google Scholar

4. Arai M, Tomaru K, Takizawa T, Sekguchi K, Yokoyama T, Suzuki T, et al. Sarcoplasmic reticulum genes are selectively down-regulated in cardiomiopathy produced by doxorubicin in rabbits. J Moll Cell Cardiol. 1998;30:243-54.10.1006/jmcc.1997.05889515001Search in Google Scholar

5. Gambliel HA, Burke BE, Cusack BJ, Walsh GM, Zhang YL, Mushlin PS, et al. Doxorubicin and C-13 deoxydoxorubicin effects on ryanodine receptor gene expression. Biochem. Biophys. Res. Commun. 2002;291:433-8.Search in Google Scholar

6. Jensen RA. Doxorubicin cardiotoxicity: contractile changes after long-term treatment in the rat. J. Pharmacol. Exp. Ther. 1986;236:197-203.Search in Google Scholar

7. Ryan T, Sharma P, Ignatchenko A, MacLennan DH, Kislinger T, Gramolini AO. Identification of novel ryanodine receptor 1 (RyR1) protein interaction with calcium homeostasis endoplasmic reticulum protein (CHERP). J. Biol. Chem. 2011;286(19):17060–8.Search in Google Scholar

8. Dudka J. Rola reaktywnych form tlenu i azotu w zaburzeniach komórkowej homeostazy wapnia i żelaza w kardiotoksyczności antracyklinowej. Postepy Hig Med Dosw. 2006;60:241-7.Search in Google Scholar

9. Vangheluwe P, Wuytack F. Improving cardiac Ca2+ transport into the sarcoplasmic reticulum in heart failure: lessons from the ubiquitous SERCA2b Ca2+ pump. Biochem Soc Trans. 2011;39:781–7.10.1042/BST039078121599649Search in Google Scholar

10. Arbabian A, Brouland JP, Gélébart P, Kovàcs T, Bobe R, Enouf J, et al. Endoplasmic reticulum calcium pumps and cancer. Biofactors. 2011;37(3): 139-49.10.1002/biof.14221674635Search in Google Scholar

11. Olson RD, Gambiel HA, Vestal RE, Shadle SE, Charlier HAJr, Cusack BJ. Doxorubicin cardiac dysfunction: Effects on calcium regulatory proteins, sarcoplasmic reticulum, and triiodothyronine. Cardiovasc. Tox. 2005;05:269-83.Search in Google Scholar

12. Korga A, Dudka J, Burdan F, Sliwinska J, Mandziuk S, Dawidek-Pietryka K. The redox imbalance and the reduction of contractile protein content in rat hearts administered with L-thyroxine and Doxorubicin. Oxid Med Cell Longev. 2012;681367.10.1155/2012/681367331706122530076Search in Google Scholar

13. Szuławska A, Czyż M. Molekularne mechanizmy działania antracyklin. Postepy Hig Med. Dosw. 2006;60:78-100.Search in Google Scholar

14. Ranek MJ, Wang X. Activation of the ubiquitin proteasome system in doxorubicin cardiomiopathy. Curr Hypertens Rep. 2009;11(6):389-95.10.1007/s11906-009-0068-8283122219895749Open DOISearch in Google Scholar

15. Ondrias K, Borgatta L, Kim DH, Ehrlich BE. Biphasic effects of Doxorubicin on the calcium release channel from sarcoplasmic reticulum of cardiac muscle. Circulation Research. 1990;67:1167-73.10.1161/01.RES.67.5.11672171802Search in Google Scholar

16. Kim SY, Kim SJ, Kim BJ, Rah SY, Chung SM, Im MJ, et al. Doxorubicin-induced reactive oxygen species generation and intracellular Ca2+ increase are reciprocally modulated in ratcardiomyocytes. Exp Mol Med. 2006;38(5):535-45.10.1038/emm.2006.6317079870Open DOISearch in Google Scholar

17. Jamroziak K. Terapia nawrotowego i opornego szpiczaka plazmocytowego. Hematologia, 2011;2(1):116–30.Search in Google Scholar

18. Lyu YL, Kerrigan JE, Lin CP, Azarova AM, Tsai YC, Ban Y, et al. Topoisomerase IIβ-mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane. Cancer Res. 2007;67:8839-46.10.1158/0008-5472.CAN-07-164917875725Search in Google Scholar

19. Boucek RJJr, Miracle A, Anderson M, Engelman R, Atkinson J, Dodd DA. Persistent effects of doxorubicin on cardiac gene expression. J Mol Cell Cardiol. 1999;31(8):1435-46.10.1006/jmcc.1999.097210423342Search in Google Scholar